BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1226155)

  • 1. [Protective effect of beta-adrenergic substances on the allergic rhinitis (author's transl)].
    Jorde W; Bohlmann HG; Linsenmann P; Werdermann K
    Med Klin; 1975 Aug; 70(32-33):1314-6. PubMed ID: 1226155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-allergic effect of the beta 2-adrenergic agent fenoterol in the nose.
    Borum P; Mygind N; Larsen FS
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():44-9. PubMed ID: 6352305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis.
    Wang D; Clement P; Smitz J; De Waele M
    Acta Otorhinolaryngol Belg; 1996; 50(1):25-32. PubMed ID: 8669268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study.
    Horak F; Matthes H
    Ann Allergy; 1982 May; 48(5):305-8. PubMed ID: 7044195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reduction of reactivity to allergic rhinitis with intravenous administration of calcium. Clinical-experimental study on the effect of changes of local airway resistance after nasal allergen provocation].
    Bachert C; Drechsler S; Keilmann A; Seifert E; Schmidt R; Welzel D
    Arzneimittelforschung; 1990 Sep; 40(9):984-7. PubMed ID: 2080949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of hydroxyzine and phenylpropanolamine in the challenged allergic nose.
    Brooks CD; Nelson A; Parzyck R; Maile MH
    Ann Allergy; 1981 Nov; 47(5 Pt 1):316-9. PubMed ID: 7316247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of eosinophil rate after nasal provocation test in allergic rhinitis diagnosis.
    Escudero Pastor A; Negro Alvarez JM; Sola Pérez J; Soriano Gomis V; Mora González A; Sánchez-Guerrero Villajos I; García Sellés FJ; López Sánchez JD; Pagán Alemán JA; Campos Aranda M
    Allergol Immunopathol (Madr); 1992; 20(5):201-5. PubMed ID: 1292329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
    Kyrein HJ; Horak F; Nirnberger G; Rehn D
    Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.
    Russo C; Zeng D; Prosperini G; Spicuzza L; Guarino F; Polosa R
    Clin Exp Allergy; 2005 Sep; 35(9):1192-6. PubMed ID: 16164447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis].
    Tahamiler R; Saritzali G; Canakçioğlu S
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):30-6. PubMed ID: 17483609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal airway response to infused phenylephrine in normals and in patients with allergic and non-allergic rhinitis.
    Brooks CD; Spenner GC; Karl KJ; Heissler CT; Metzler CM
    Rhinology; 1988 Mar; 26(1):51-8. PubMed ID: 3368711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of locally applied ipratropium aerosol on the nasal methacholine challenge in patients with allergic and non-allergic rhinitis.
    Sanwikarja S; Schmitz PI; Dieges PH
    Ann Allergy; 1986 Feb; 56(2):162-6. PubMed ID: 2936282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effect of acupuncture on allergen provoked rhinitis].
    Wolkenstein E; Horak F
    Wien Med Wochenschr; 1998; 148(19):450-3. PubMed ID: 10025043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of beclomethasone dipropionate treatment on the nasal provocation test.
    Clement PA; Kaufman L
    Rhinology; 1984 Sep; 22(3):183-91. PubMed ID: 6505518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between allergen-specific skin testing and nasal provocation in patients with perennial rhinitis.
    Small P; Biskin N
    Ann Allergy; 1992 Apr; 68(4):331-3. PubMed ID: 1373048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cryptoporus polysaccharide on rat allergic rhinitis associated with inhibiting eotaxin mRNA expression.
    Xie QM; Deng JF; Deng YM; Shao CS; Zhang H; Ke CK
    J Ethnopharmacol; 2006 Oct; 107(3):424-30. PubMed ID: 16765544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis.
    Boot JD; de Kam ML; Mascelli MA; Miller B; van Wijk RG; de Groot H; Cohen AF; Diamant Z
    Allergy; 2007 Apr; 62(4):378-84. PubMed ID: 17362248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic blockade does not alter the nasal congestive response to irritant provocation.
    Shusterman D; Murphy MA; Walsh P; Balmes JR
    Rhinology; 2002 Sep; 40(3):141-6. PubMed ID: 12357714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.